1. Home
  2. ERO vs IOVA Comparison

ERO vs IOVA Comparison

Compare ERO & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERO
  • IOVA
  • Stock Information
  • Founded
  • ERO 2016
  • IOVA 2007
  • Country
  • ERO Canada
  • IOVA United States
  • Employees
  • ERO N/A
  • IOVA N/A
  • Industry
  • ERO
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ERO
  • IOVA Health Care
  • Exchange
  • ERO Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • ERO 1.3B
  • IOVA 1.0B
  • IPO Year
  • ERO N/A
  • IOVA N/A
  • Fundamental
  • Price
  • ERO $13.42
  • IOVA $1.69
  • Analyst Decision
  • ERO Strong Buy
  • IOVA Strong Buy
  • Analyst Count
  • ERO 1
  • IOVA 9
  • Target Price
  • ERO $19.00
  • IOVA $18.22
  • AVG Volume (30 Days)
  • ERO 491.2K
  • IOVA 9.3M
  • Earning Date
  • ERO 05-05-2025
  • IOVA 05-08-2025
  • Dividend Yield
  • ERO N/A
  • IOVA N/A
  • EPS Growth
  • ERO N/A
  • IOVA N/A
  • EPS
  • ERO 0.18
  • IOVA N/A
  • Revenue
  • ERO $489,554,000.00
  • IOVA $164,070,000.00
  • Revenue This Year
  • ERO $75.21
  • IOVA $182.20
  • Revenue Next Year
  • ERO $18.98
  • IOVA $62.10
  • P/E Ratio
  • ERO $73.22
  • IOVA N/A
  • Revenue Growth
  • ERO 13.24
  • IOVA 13698.99
  • 52 Week Low
  • ERO $9.30
  • IOVA $2.70
  • 52 Week High
  • ERO $24.34
  • IOVA $13.60
  • Technical
  • Relative Strength Index (RSI)
  • ERO 60.88
  • IOVA 24.56
  • Support Level
  • ERO $13.22
  • IOVA $3.02
  • Resistance Level
  • ERO $14.29
  • IOVA $3.31
  • Average True Range (ATR)
  • ERO 0.46
  • IOVA 0.24
  • MACD
  • ERO 0.21
  • IOVA -0.08
  • Stochastic Oscillator
  • ERO 77.07
  • IOVA 6.00

About ERO Ero Copper Corp.

Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: